Skip to main content
. 2025 Apr 1;23(4):154. doi: 10.3390/md23040154
ATS
ECG
OMT
Atherosclerotic
Electrocardiogram
Optimal Medical Therapy
BMI Body Mass Index
NSTE-ACS
Omega-3 PUFAs
group of patients with Non-ST elevation acute coronary syndromes treated with Omega-3 fatty acids (Omacor®) in addition to OMT
NSTE-ACS group of patients with Non-ST elevation acute coronary syndromes with OMT without Omega-3 fatty acids (Omacor®)
STE-ACS
Omega-3 PUFAs
group of patients with ST elevation acute coronary syndromes treated with Omega-3 fatty acids (Omacor®) in addition to OMT
STE-ACS group of patients with n ST elevation acute coronary syndromes with OMT without Omega-3 fatty acids (Omacor®)
LDL Cholesterol Low Density Lipoprotein Cholesterol
HDL Cholesterol High Density Lipoprotein Cholesterol
CK-MB ACEI Creatine Kinase isoenzymes MB Angiotensin Converting Enzymes Inhibitors
FMD
vWf
TAS
Flow-Mediated Dilation
von Willebrand factor
Total Antioxidant Status
Ab anti Ox LDL
cholesterol
antibodies anti-Oxidated Low Density Lipoprotein Cholesterol
Ac anti
MPO IgG
Antibodies anti-Myeloperoxidase Immunoglobulin G type